ESC TV Today – Your Cardiovascular News  By  cover art

ESC TV Today – Your Cardiovascular News

By: European Society of Cardiology
  • Summary

  • The European Society of Cardiology brings you the most relevant news in cardiovascular medicine, opinions from leading experts, and insight into the latest developments in our field that really matter. You can also be interested in other ESC podcasts: ESC Cardio Talk, EHRA Cardio Talk and HFA Cardio Talk. Check them out!
    The entire contents of these podcasts are subject to ESC copyright (all rights reserved).
    Show more Show less
Episodes
  • Season 2 - Ep.17: State-of-affairs in hypertension treatment - Anticoagulation in pregnancy
    Jun 6 2024

    ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly.

    This episode covers:

    Cardiology This Week: A concise summary of recent studies

    State-of-affairs in hypertension treatment

    Anticoagulation in pregnancy

    Statistics Made Easy : Accuracy and AUC

    Host: Perry Elliott

    Guests: Carlos Aguiar, Gianfranco Parati, Julie De Backer

    Want to watch that episode? Go to: https://esc365.escardio.org/event/1152

    Disclaimer

    This programme is intended for health care professionals only and is to be used for educational purposes.

    The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices.

    Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.

    Declarations of interests

    Stephan Achenbach, Julie De Backer and Nicolle Kraenkel have declared to have no potential conflicts of interest to report.

    Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, Lilly, Novartis, Pfizer, Sanofi, Servier, Tecnimede.

    Davide Capodanno has declared to have potential conflicts of interest to report: Abbott Vascular, Novo Nordisk, Sanofi. Terumo, Medtronic.

    Perry Elliott has declared to have potential conflicts of interest to report: consultancies for Pfizer, BMS, Cytokinetics.

    Gianfranco Parati has declared to have potential conflicts of interest to report: honoraria for lectures by Omron, Viatris, Merck, Recor, Somnomedics.

    Emma Svennberg has declared to have potential conflicts of interest to report: institutional research grants from Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Boehringer-Ingelheim, Johnson & Johnson, Merck Sharp & Dohme.

    Show more Show less
    26 mins
  • Season 2 - Ep.16: Long-term beta blockers after MI - Pros and Cons of the microaxial pump in cardiogenic shock
    May 23 2024

    ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly.

    This episode covers:

    Cardiology This Week: A concise summary of recent studies

    Long-term beta blockers after myocardial infarction

    Pros and Cons of the microaxial pump in cardiogenic shock

    Snapshots

    Host: Perry Elliott

    Guests: Stephan Achenbach, Carlos Aguiar, Michael Boehm, Lene Holmvang

    Want to watch that episode? Go to: https://esc365.escardio.org/event/1151

    Disclaimer

    This programme is intended for health care professionals only and is to be used for educational purposes.

    The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices.

    Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.

    Declarations of interests

    Stephan Achenbach, Michael Boehm, Lene Holmvang and Nicolle Kraenkel have declared to have no potential conflicts of interest to report.

    Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, Lilly, Novartis, Pfizer, Sanofi, Servier, Tecnimede.

    Davide Capodanno has declared to have potential conflicts of interest to report: Abbott Vascular, Novo Nordisk, Sanofi. Terumo, Medtronic.

    Emma Svennberg has declared to have potential conflicts of interest to report: institutional research grants from Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Boehringer-Ingelheim, Johnson & Johnson, Merck Sharp & Dohme.

    Show more Show less
    17 mins
  • Season 2 - Ep.15: Omega-3 fatty acids - Lead induced tricuspid regurgitation
    May 9 2024

    ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly.

    This episode covers:

    • Cardiology This Week: A concise summary of recent studies
    • All you need to know about omega-3 fatty acids
    • Lead induced tricuspid regurgitation
    • MythBusters: Pomegranates are heart-healthy

    Host: Rick Grobbee

    Guests: Carlos Aguiar, Martin Andreas, Deepak Bhatt

    Want to watch that episode? Go to: https://esc365.escardio.org/event/1150

    Disclaimer

    This programme is intended for health care professionals only and is to be used for educational purposes.

    The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices.

    Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.

    Declarations of interests

    Stephan Achenbach, Rick Grobbee and Nicolle Kraenkel have declared to have no potential conflicts of interest to report.

    Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, Lilly, Novartis, Pfizer, Sanofi, Servier, Tecnimede.

    Martin Andreas has declared to have potential conflicts of interest to report: proctor/speaker/consultant (Edwards, Abbott, Medtronic, Boston, Braun, Zoll) and institutional Research Grants (Edwards, Abbott, Medtronic, LSI).

    Deepak Bhatt has declared to have potential conflicts of interest to report: research funding from Amarin paid to Brigham and Women’s Hospital and the Icahn School of Medicine at Mount Sinai for my role as Principal Investigator of REDUCE-IT.

    Davide Capodanno has declared to have potential conflicts of interest to report: Abbott Vascular, Novo Nordisk, Sanofi. Terumo, Medtronic.

    Emma Svennberg has declared to have potential conflicts of interest to report: institutional research grants from Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Boehringer-Ingelheim, Johnson & Johnson, Merck Sharp & Dohme.

    Show more Show less
    22 mins

What listeners say about ESC TV Today – Your Cardiovascular News

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.